Učitavanje...
Complement Inhibition: A Novel Form of Immunotherapy for Colon Cancer
BACKGROUND: Complement is a central part of both the innate and adaptive immune response and its activation has traditionally been considered part of the immunosurveillance response against cancer. Its pro-inflammatory role and its contribution to the development of many illnesses associated with in...
Spremljeno u:
| Izdano u: | Ann Surg Oncol |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5733728/ https://ncbi.nlm.nih.gov/pubmed/26289805 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1245/s10434-015-4778-7 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|